Cargando…
Bergenin Exerts Hepatoprotective Effects by Inhibiting the Release of Inflammatory Factors, Apoptosis and Autophagy via the PPAR-γ Pathway
OBJECTIVE: Hepatic ischemia reperfusion (IR) limits the development of liver transplantation technology. The aim of this study was to explore the protective effects of Bergenin on hepatic IR, particularly the elimination of reactive oxygen species (ROS) and activation of the peroxisome proliferators...
Autores principales: | Xiang, Shihao, Chen, Kan, Xu, Ling, Wang, Ting, Guo, Chuanyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970010/ https://www.ncbi.nlm.nih.gov/pubmed/32021098 http://dx.doi.org/10.2147/DDDT.S229063 |
Ejemplares similares
-
Bergenin Attenuates Hepatic Fibrosis by Regulating Autophagy Mediated by the PPAR-γ/TGF-β Pathway
por: Xia, Yujing, et al.
Publicado: (2020) -
Bergenin, Acting as an Agonist of PPARγ, Ameliorates Experimental Colitis in Mice through Improving Expression of SIRT1, and Therefore Inhibiting NF-κB-Mediated Macrophage Activation
por: Wang, Kai, et al.
Publicado: (2018) -
PPARγ and Apoptosis in Cancer
por: Elrod, Heath A., et al.
Publicado: (2008) -
The Hepatoprotection by Oleanolic Acid Preconditioning: Focusing on PPARα Activation
por: Wang, Wenwen, et al.
Publicado: (2018) -
Therapeutic potential of PPARγ natural agonists in liver diseases
por: Wu, Liwei, et al.
Publicado: (2020)